Holen Sie sich die Stockscreener-App
21.25
1.17%
0.215
Schlusskurs vom Vortag:
$21.03
Offen:
$21.06
24-Stunden-Volumen:
20,575
Relative Volume:
0.03
Marktkapitalisierung:
$924.83M
Einnahmen:
$78.02M
Nettoeinkommen (Verlust:
$-73.37M
KGV:
-16.09
EPS:
-1.32
Netto-Cashflow:
$-62.06M
1W Leistung:
-3.08%
1M Leistung:
-19.44%
6M Leistung:
+95.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$20.80
$21.43
1-Wochen-Bereich:
$20.80
$23.41
52-Wochen-Spanne:
$8.89
$26.66
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
21.27 | 914.18M | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
131.27 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.70 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
365.51 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.10 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.16 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Midday Stock Roundup: EnVVeno down 15% - Orange County Business Journal
Beta Bionics Inc. stock prediction for this week2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Using Python tools to backtest Beta Bionics Inc. strategiesEntry Point & Step-by-Step Swing Trade Plans - newser.com
What analysts say about Beta Bionics Inc stockEx-Dividend Date Alerts & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
What Fibonacci levels say about Beta Bionics Inc. reboundWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
How to manage a losing position in Beta Bionics Inc.Weekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
How to forecast Beta Bionics Inc. trends using time seriesExit Point & Risk Adjusted Swing Trade Ideas - newser.com
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 - GlobeNewswire
Relative strength of Beta Bionics Inc. in sector analysisTrend Reversal & High Conviction Trade Alerts - newser.com
How Beta Bionics Inc. stock reacts to bond yieldsRate Hike & Precise Swing Trade Entry Alerts - newser.com
Beta Bionics, Inc. (NASDAQ:BBNX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Beta Bionics Inc Stock Analysis and ForecastDouble Top/Bottom Patterns & Exceptional Capital Growth - earlytimes.in
Live market analysis of Beta Bionics Inc.Quarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Is this a good reentry point in Beta Bionics Inc.2025 Top Decliners & Free Risk Controlled Daily Trade Plans - newser.com
Will Beta Bionics Inc. stock deliver strong dividend growth2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Beta Bionics Inc. stock volume spike explainedInsider Selling & Weekly Top Gainers Trade List - newser.com
Goldman Sachs Upgrades Beta Bionics (BBNX) - Nasdaq
How institutional ownership impacts Beta Bionics Inc. stockMarket Volume Summary & High Conviction Buy Zone Picks - newser.com
Goldman Sachs Upgrades Beta Bionics to Buy From Neutral, Adjusts Price Target to $26 From $18 - MarketScreener
Goldman Sachs upgrades Beta Bionics stock to Buy on diabetes tech growth By Investing.com - Investing.com South Africa
Goldman Sachs upgrades Beta Bionics stock to Buy on diabetes tech growth - Investing.com
Top chart patterns to watch in Beta Bionics Inc.Weekly Trend Report & High Conviction Buy Zone Picks - newser.com
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Beta Bionics Inc-Aktie (BBNX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Feider Stephen | Chief Financial Officer |
Oct 03 '25 |
Sale |
21.69 |
4,982 |
108,076 |
44,041 |
| Feider Stephen | Chief Financial Officer |
Oct 01 '25 |
Option Exercise |
5.10 |
15,018 |
76,592 |
59,059 |
| Feider Stephen | Chief Financial Officer |
Oct 01 '25 |
Sale |
20.76 |
15,018 |
311,806 |
44,041 |
0.14%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):